Danaher Buys Filtration Firm Pall, Will Split Into Two
This article was originally published in The Gray Sheet
The major acquisition will be followed by a company split – the Danaher name will stay with the business that includes diagnostics and dental segments, and a second, more industrial-focused company will be formed by the end of 2016.
You may also be interested in...
Diagnostics Reform Reintroduced in House
The VALID Act, which will hand diagnostics oversight to the US FDA, has been reintroduced in the House of Representatives after it failed twice last year in Congress.
Cytokinetics’ Failure In ALS Clears Way For Focus On Aficamten
With a data monitoring committee finding no signs of efficacy in a Phase III trial of ALS candidate reldesemtiv, Cytokinetics can conserve cash and center on aficamten for hypertrophic cardiomyopathy.